Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP918105.RA2d5LtAxhRIeGbRGE8_4_ETq_KEvZ0nBaL44ZeOoPoq0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP918105.RA2d5LtAxhRIeGbRGE8_4_ETq_KEvZ0nBaL44ZeOoPoq0130_assertion type Assertion NP918105.RA2d5LtAxhRIeGbRGE8_4_ETq_KEvZ0nBaL44ZeOoPoq0130_head.
- NP918105.RA2d5LtAxhRIeGbRGE8_4_ETq_KEvZ0nBaL44ZeOoPoq0130_assertion description "[This study evaluated the potential of recombinant pen-2 (rPen-2) in the selective killing of kidney cancer cell lines ACHN and A498, and its action mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP918105.RA2d5LtAxhRIeGbRGE8_4_ETq_KEvZ0nBaL44ZeOoPoq0130_provenance.
- NP918105.RA2d5LtAxhRIeGbRGE8_4_ETq_KEvZ0nBaL44ZeOoPoq0130_assertion evidence source_evidence_literature NP918105.RA2d5LtAxhRIeGbRGE8_4_ETq_KEvZ0nBaL44ZeOoPoq0130_provenance.
- NP918105.RA2d5LtAxhRIeGbRGE8_4_ETq_KEvZ0nBaL44ZeOoPoq0130_assertion SIO_000772 25135722 NP918105.RA2d5LtAxhRIeGbRGE8_4_ETq_KEvZ0nBaL44ZeOoPoq0130_provenance.
- NP918105.RA2d5LtAxhRIeGbRGE8_4_ETq_KEvZ0nBaL44ZeOoPoq0130_assertion wasDerivedFrom befree-20150227 NP918105.RA2d5LtAxhRIeGbRGE8_4_ETq_KEvZ0nBaL44ZeOoPoq0130_provenance.
- NP918105.RA2d5LtAxhRIeGbRGE8_4_ETq_KEvZ0nBaL44ZeOoPoq0130_assertion wasGeneratedBy ECO_0000203 NP918105.RA2d5LtAxhRIeGbRGE8_4_ETq_KEvZ0nBaL44ZeOoPoq0130_provenance.